Name | Number of supported studies | Average coverage | |
---|---|---|---|
neutrophil | 4 studies | 25% ± 8% |
Insufficient scRNA-seq data for expression of FFAR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 60% | 81.41 | 148 / 245 | 97% | 20.47 | 486 / 502 |
lung | 97% | 726.59 | 563 / 578 | 58% | 3.39 | 673 / 1155 |
breast | 69% | 216.64 | 318 / 459 | 69% | 5.77 | 770 / 1118 |
spleen | 100% | 2165.45 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.86 | 1 / 1 |
esophagus | 36% | 48.05 | 514 / 1445 | 62% | 3.23 | 114 / 183 |
peripheral blood | 98% | 13708.29 | 909 / 929 | 0% | 0 | 0 / 0 |
intestine | 30% | 45.94 | 289 / 966 | 65% | 3.72 | 345 / 527 |
stomach | 26% | 50.92 | 93 / 359 | 62% | 3.19 | 176 / 286 |
adipose | 82% | 274.42 | 982 / 1204 | 0% | 0 | 0 / 0 |
skin | 36% | 30.94 | 651 / 1809 | 36% | 1.10 | 170 / 472 |
tonsil | 0% | 0 | 0 / 0 | 71% | 3.04 | 32 / 45 |
bladder | 19% | 44.10 | 4 / 21 | 52% | 2.78 | 260 / 504 |
liver | 50% | 67.76 | 114 / 226 | 12% | 0.45 | 50 / 406 |
eye | 0% | 0 | 0 / 0 | 61% | 1.91 | 49 / 80 |
uterus | 9% | 12.76 | 15 / 170 | 52% | 2.53 | 237 / 459 |
pancreas | 4% | 2.75 | 14 / 328 | 56% | 4.12 | 99 / 178 |
lymph node | 0% | 0 | 0 / 0 | 59% | 6.62 | 17 / 29 |
thymus | 31% | 31.88 | 205 / 653 | 10% | 0.20 | 60 / 605 |
kidney | 24% | 19.47 | 21 / 89 | 17% | 0.37 | 154 / 901 |
heart | 28% | 32.66 | 243 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 12% | 11.44 | 30 / 258 | 10% | 0.58 | 23 / 230 |
brain | 6% | 5.39 | 170 / 2642 | 7% | 0.13 | 46 / 705 |
blood vessel | 13% | 16.85 | 172 / 1335 | 0% | 0 | 0 / 0 |
ovary | 3% | 2.48 | 5 / 180 | 7% | 0.26 | 28 / 430 |
muscle | 3% | 1.81 | 24 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0002752 | Biological process | cell surface pattern recognition receptor signaling pathway |
GO_0002385 | Biological process | mucosal immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_1990806 | Biological process | ligand-gated ion channel signaling pathway |
GO_0046676 | Biological process | negative regulation of insulin secretion |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0002673 | Biological process | regulation of acute inflammatory response |
GO_0019915 | Biological process | lipid storage |
GO_0002879 | Biological process | positive regulation of acute inflammatory response to non-antigenic stimulus |
GO_0090276 | Biological process | regulation of peptide hormone secretion |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0002232 | Biological process | leukocyte chemotaxis involved in inflammatory response |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045444 | Biological process | fat cell differentiation |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0005886 | Cellular component | plasma membrane |
GO_0042995 | Cellular component | cell projection |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0008289 | Molecular function | lipid binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FFAR2 |
Protein name | Fatty acid receptor 2 Free fatty acid receptor 2 (G-protein coupled receptor 43) Free fatty acid receptor 2 |
Synonyms | FFA2 GPR43 GPCR43 |
Description | FUNCTION: G protein-coupled receptor that is activated by a major product of dietary fiber digestion, the short chain fatty acids (SCFAs), and that plays a role in the regulation of whole-body energy homeostasis and in intestinal immunity. In omnivorous mammals, the short chain fatty acids acetate, propionate and butyrate are produced primarily by the gut microbiome that metabolizes dietary fibers. SCFAs serve as a source of energy but also act as signaling molecules. That G protein-coupled receptor is probably coupled to the pertussis toxin-sensitive, G(i/o)-alpha family of G proteins but also to the Gq family . Its activation results in the formation of inositol 1,4,5-trisphosphate, the mobilization of intracellular calcium, the phosphorylation of the MAPK3/ERK1 and MAPK1/ERK2 kinases and the inhibition of intracellular cAMP accumulation. May play a role in glucose homeostasis by regulating the secretion of GLP-1, in response to short-chain fatty acids accumulating in the intestine. May also regulate the production of LEP/Leptin, a hormone acting on the central nervous system to inhibit food intake. Finally, may also regulate whole-body energy homeostasis through adipogenesis regulating both differentiation and lipid storage of adipocytes. In parallel to its role in energy homeostasis, may also mediate the activation of the inflammatory and immune responses by SCFA in the intestine, regulating the rapid production of chemokines and cytokines. May also play a role in the resolution of the inflammatory response and control chemotaxis in neutrophils. In addition to SCFAs, may also be activated by the extracellular lectin FCN1 in a process leading to activation of monocytes and inducing the secretion of interleukin-8/IL-8 in response to the presence of microbes . Among SCFAs, the fatty acids containing less than 6 carbons, the most potent activators are probably acetate, propionate and butyrate . Exhibits a SCFA-independent constitutive G protein-coupled receptor activity . . |
Accessions | ENST00000599180.3 A0A0C5K8I6 C6KYL4 O15552 ENST00000246549.2 |